Rezolute, Inc. Common Stock (NV)
Symbol: RZLT (NASDAQ)
8.10
0.00 0.000
Company Description:
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Key Stats
- Today's Open: $8.265
- Today's High: $8.265
- Today's Low: $7.967
- Today's Volume: 292
- Yesterday Close: $8.1
- Yesterday High: $8.335
- Yesterday Low: $8.05
- Yesterday Volume: 664.78K
- Last Min Volume: 10
- Last Min High: $8.1
- Last Min Low: $8.1
- Last Min VWAP: $8.1
Company Profile
- Name: Rezolute, Inc. Common Stock (NV)
- Website: https://www.rezolutebio.com
- Listed Date: 2011-12-23
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001509261
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $704.67M
- Round Lot: 100
- Outstanding Shares: 87.00M
- Asset Type: CS
RECENT FILINGS FOR RZLT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 8-K | View |
| 2025-08-27 | 4 | View |
| 2025-08-27 | 3 | View |
| 2025-08-20 | 8-K | View |
| 2025-08-08 | EFFECT | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-01 | CORRESP | View |
| 2025-07-24 | UPLOAD | View |
| 2025-07-18 | 8-K | View |
| 2025-07-17 | S-3 | View |
| 2025-06-26 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 8-K/A | View |
| 2025-06-13 | 8-K | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-12 | 4 | View |
Latest News on RZLT